Investigators at Tel Aviv University and the Rabin Medical Center in Israel assessed the impact of cannabis exposure on motor symptoms and pain parameters in patients with Parkinson's disease.
Researchers reported that cannabis inhalation was associated with improved symptoms 30-minutes following exposure. "Cannabis improved motor scores and pain symptoms in PD patients," authors concluded.
A prior Israeli trial evaluating the impact of cannabis on PD patients reported "significant improvement after treatment in tremor, rigidity, and bradykinsea (slowness of movement) ... [as well as] significant improvement of sleep and pain scores."
Over 20,000 Israeli patients receive cannabis under a federally regulated program. Over 90 percent of those participants report significant improvements in pain and function as a result of their medicinal cannabis use.
For more information, please contact Paul Armentano, NORML Deputy Director, at: firstname.lastname@example.org. Full text of the study, "Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson's disease," appears in the European Journal of Pain.